BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND ZRSR2, URP, 8233, ENSG00000169249, U2AF1RS2, MGC142040, U2AF1L2, U2AF1-RS2, MGC142014
14 results:

  • 1. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
    Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutated zrsr2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
    Fukuchi K; Koyama D; Takada M; Mori H; Hayashi K; Asano N; Sato Y; Fukatsu M; Takano M; Takahashi H; Shirado-Harada K; Kimura S; Yamamoto T; Ikezoe T
    Int J Hematol; 2023 Oct; 118(4):489-493. PubMed ID: 37029861
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.
    Zhang B; Zhang Y; Li Q; Jiang Q; Chu W; Gong H; Li R; Ji H
    Pathol Oncol Res; 2022; 28():1610653. PubMed ID: 36567979
    [No Abstract]    [Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
    Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
    Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
    Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
    Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology.
    Karantanos T; Jain T; Moliterno AR; Jones RJ; DeZern AE
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807519
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
    Nazha A; Hu ZH; Wang T; Lindsley RC; Abdel-Azim H; Aljurf M; Bacher U; Bashey A; Cahn JY; Cerny J; Copelan E; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla SM; Gale RP; George B; Gergis U; Grunwald MR; Hamilton B; Hashmi S; Hildebrandt GC; Inamoto Y; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Lazarus HM; Liesveld JL; Litzow MR; Majhail NS; Murthy HS; Nathan S; Nishihori T; Pawarode A; Rizzieri D; Sabloff M; Savani BN; Schachter L; Schouten HC; Seo S; Shah NN; Solh M; Valcárcel D; Vij R; Warlick E; Wirk B; Wood WA; Yared JA; Alyea E; Popat U; Sobecks RM; Scott BL; Nakamura R; Saber W
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2139-2146. PubMed ID: 32781289
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Complex landscape of alternative splicing in myeloid neoplasms.
    Hershberger CE; Moyer DC; Adema V; Kerr CM; Walter W; Hutter S; Meggendorfer M; Baer C; Kern W; Nadarajah N; Twardziok S; Sekeres MA; Haferlach C; Haferlach T; Maciejewski JP; Padgett RA
    Leukemia; 2021 Apr; 35(4):1108-1120. PubMed ID: 32753690
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.
    Madan V; Li J; Zhou S; Teoh WW; Han L; Meggendorfer M; Malcovati L; Cazzola M; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Am J Hematol; 2020 Feb; 95(2):133-143. PubMed ID: 31680297
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm.
    Szczepaniak A; Machnicki M; Gniot M; Pępek M; Rydzanicz M; Płoski R; Kaźmierczak M; Stokłosa T; Lewandowski K
    Int J Hematol; 2019 Jul; 110(1):102-106. PubMed ID: 30977107
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.
    Janusz K; Del Rey M; Abáigar M; Collado R; Ivars D; Hernández-Sánchez M; Valiente A; Robledo C; Benito R; Díez-Campelo M; Ramos F; Kohlmann A; Cañizo CD; Hernández-Rivas JM
    Leuk Res; 2017 May; 56():82-87. PubMed ID: 28222336
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).
    Berman E; Jhanwar S; Hedvat C; Arcila ME; Wahab OA; Levine R; Maloy M; Ma W; Albitar M
    Leuk Res; 2016 Oct; 49():108-12. PubMed ID: 27658269
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aberrant splicing of U12-type introns is the hallmark of zrsr2 mutant myelodysplastic syndrome.
    Madan V; Kanojia D; Li J; Okamoto R; Sato-Otsubo A; Kohlmann A; Sanada M; Grossmann V; Sundaresan J; Shiraishi Y; Miyano S; Thol F; Ganser A; Yang H; Haferlach T; Ogawa S; Koeffler HP
    Nat Commun; 2015 Jan; 6():6042. PubMed ID: 25586593
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
    Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
    Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.